213 related articles for article (PubMed ID: 28270085)
1. The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade.
Xu Q; Wang L; Luo J; Shi D
Curr Drug Targets; 2018; 19(1):55-69. PubMed ID: 28270085
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches to drug discovery for the treatment of type 2 diabetes.
Xu X; Wang G; Zhou T; Chen L; Chen J; Shen X
Expert Opin Drug Discov; 2014 Sep; 9(9):1047-58. PubMed ID: 25054271
[TBL] [Abstract][Full Text] [Related]
3. Non-insulin dependent diabetes mellitus: present therapies and new drug targets.
Das SK; Chakrabarti R
Mini Rev Med Chem; 2005 Nov; 5(11):1019-34. PubMed ID: 16307531
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?
Ampofo E; Nalbach L; Menger MD; Montenarh M; Götz C
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500224
[TBL] [Abstract][Full Text] [Related]
6. G-protein-coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives.
Sebastiani G; Ceccarelli E; Castagna MG; Dotta F
Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):201-213. PubMed ID: 29678286
[TBL] [Abstract][Full Text] [Related]
7. Past and current perspective on new therapeutic targets for Type-II diabetes.
Patil PD; Mahajan UB; Patil KR; Chaudhari S; Patil CR; Agrawal YO; Ojha S; Goyal SN
Drug Des Devel Ther; 2017; 11():1567-1583. PubMed ID: 28579755
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Intervention in Type 2 Diabetes Mellitus - A Pathophysiologically Reasoned Approach?
Forst T; Heise T; Plum-Morschel L
Curr Diabetes Rev; 2016; 12(4):429-439. PubMed ID: 27296043
[TBL] [Abstract][Full Text] [Related]
9. Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.
Raskin P
Diabetes Metab Res Rev; 2013 Jul; 29(5):347-56. PubMed ID: 23463735
[TBL] [Abstract][Full Text] [Related]
10. Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus.
Ramírez-Alarcón K; Victoriano M; Mardones L; Villagran M; Al-Harrasi A; Al-Rawahi A; Cruz-Martins N; Sharifi-Rad J; Martorell M
Front Endocrinol (Lausanne); 2021; 12():656978. PubMed ID: 34140928
[TBL] [Abstract][Full Text] [Related]
11. Thoughts on the progression of type 2 diabetes drug discovery.
Bhatt HB
Expert Opin Drug Discov; 2015 Feb; 10(2):107-10. PubMed ID: 25534140
[TBL] [Abstract][Full Text] [Related]
12. Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms.
Xu L; Li Y; Dai Y; Peng J
Pharmacol Res; 2018 Apr; 130():451-465. PubMed ID: 29395440
[TBL] [Abstract][Full Text] [Related]
13. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
[TBL] [Abstract][Full Text] [Related]
14. Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus.
He ZX; Zhou ZW; Yang Y; Yang T; Pan SY; Qiu JX; Zhou SF
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):125-38. PubMed ID: 25360831
[TBL] [Abstract][Full Text] [Related]
15. G Protein-Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus.
Riddy DM; Delerive P; Summers RJ; Sexton PM; Langmead CJ
Pharmacol Rev; 2018 Jan; 70(1):39-67. PubMed ID: 29233848
[TBL] [Abstract][Full Text] [Related]
16. QSAR studies in the discovery of novel type-II diabetic therapies.
Abuhammad A; Taha MO
Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications.
Tan D; Tseng HHL; Zhong Z; Wang S; Vong CT; Wang Y
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232291
[TBL] [Abstract][Full Text] [Related]
18. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
Nadeau DA
Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
[TBL] [Abstract][Full Text] [Related]
19. Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.
Solini A
Acta Diabetol; 2016 Dec; 53(6):863-870. PubMed ID: 27038028
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment.
Yaribeygi H; Katsiki N; Behnam B; Iranpanah H; Sahebkar A
Metabolism; 2018 Oct; 87():48-55. PubMed ID: 30253864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
